A start-up business in Southampton which takes its name from a Viking hero has secured permission to brew and sell mead.

Truist analyst Patrick Scholes raised the firm’s price target on Viking Holdings (VIK) to $49 from $38 and keeps a Hold rating on the shares as ...

Viking, which has been in business for 52 years, was recently sold to the Hoffman Family of Companies, a family-owned private equity firm based in Florida. Goodsel, who earned a degree in plastics ...

In fact, Viking just gave investors an update which firms up its status as a very promising company. Here's what it reported, ...

The biotech’s liver-disease treatment is also viewed as best-in-class, earning it a full slate of buy ratings from analysts.

After 20 seasons of ownership, the Wilf family have a winning team, an always-sold-out stadium and a growing real estate ...

Analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) and keeping the price ...

Viking Holdings Ltd (the “Company” or “Viking”) (NYSE: VIK) today reported financial results for the third quarter ended September 30, 2024. “The strength of our one Viking brand and our loyal guests ...